Skip to main content
MicroPort NeuroScientic Corporation logo

MicroPort NeuroScientic Corporation — Investor Relations & Filings

Ticker · 2172 HKEX Manufacturing
Filings indexed 195 across all filing types
Latest filing 2026-04-30 Regulatory Filings
Country HK Hong Kong
Listing HKEX 2172

About MicroPort NeuroScientic Corporation

https://www.microportneurosci.com

MicroPort NeuroScientific Corporation is a medical technology company specializing in the research, development, manufacturing, and marketing of neuro-interventional medical devices. The company is dedicated to providing accessible, top-quality, and comprehensive solutions for stroke patients globally. Its product portfolio addresses complex neurovascular diseases, including intracranial aneurysms, cerebral atherosclerosis stenosis, and acute cerebral embolism. Key offerings include advanced devices such as the NUMEN coil embolization system. The corporation maintains a leading position in the neuro-interventional field, with its solutions utilized extensively across major healthcare systems.

Recent filings

Filing Released Lang Actions
Next Day Disclosure Return
Regulatory Filings
2026-04-30 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 1% confidence The document is a Hong Kong Exchange Next Day Disclosure Return (Form FF305) detailing changes in issued and treasury shares, specifically reporting a share repurchase (100,000 shares) including opening/closing balances and repurchase details. This is not a general announcement of a report or a regulatory summary but an actual transactional report of the company buying back its own shares. Therefore it falls squarely under “Transaction in Own Shares (share repurchase)” which corresponds to code POS.
2026-04-29 English
CLOSURE OF REGISTER OF MEMBERS AND RECORD DATE FOR FINAL DIVIDEND
Notice of Dividend Amount Classification · 1% confidence The document is an official corporate announcement regarding the closure of the register of members and the record date for the final dividend of the Company. It provides shareholders with the critical details needed to qualify for and receive the proposed final dividend (register closure period and record date). This fits the definition of a Notice of Dividend Amount (DIV), which includes announcements of dividend details such as payment dates and record dates. It is not the dividend declaration text itself with the amount, but in our taxonomy such notices covering record dates and related dividend logistics fall under DIV.
2026-04-29 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 1% confidence The document is a Hong Kong Stock Exchange ‘‘Next Day Disclosure Return’’ (Form FF305) filed under Main Board Rule 13.25A/GEM Rule 17.27A, detailing the company’s repurchase of its own shares (100,000 shares repurchased on 28 April 2026) and the impact on issued and treasury share balances. This is not a broader financial report, proxy statement, or dividend notice, but a regulatory announcement of a share buyback. According to the classification definitions, this corresponds to a “Transaction in Own Shares” (POS).
2026-04-28 English
2025 Annual Report
Annual Report Classification · 1% confidence The document is explicitly titled '2025 ANNUAL REPORT' and contains comprehensive sections typical of an annual report, including a Chairman's Statement, Management Discussion and Analysis, Corporate Governance Report, Environmental, Social and Governance Report, and full audited financial statements (Consolidated Statement of Profit or Loss, Financial Position, etc.). It is a full-year report for the fiscal year 2025, not an announcement or a summary. FY 2025
2026-04-27 English
Monthly Return of Equity Issuers on Movements in Securities for the month ended 31 March 2026
Regulatory Filings Classification · 1% confidence The document is a statutory monthly return (HKEX Form FF301) detailing movements in authorised/registered share capital, issued shares, treasury shares, share options, and related confirmations under the Exchange Listing Rules. It is neither an earnings announcement, annual/interim report, nor a management presentation, nor a specific proxy or dividend notice. There is no evidence of a record of voting results, director dealing, delisting, or M&A activity. It is a formal regulatory disclosure to the stock exchange. This does not fit into any of the more specific categories, so under the taxonomy it defaults to the “Regulatory Filings” (RNS) category.
2026-04-02 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.